HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.

AuthorsP Simon, W J Burlingham, R Conklin, T P Fondy
JournalCancer research (Cancer Res) Vol. 39 Issue 10 Pg. 3897-902 (Oct 1979) ISSN: 0008-5472 [Print] United States
PMID476625 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • N-bromoacetyl-beta-D-glucosamine tetra-O-acetate
  • N-bromoacetyl-beta-D-galactosamine tetra-O-acetate
  • Galactosamine
  • Acetylgalactosamine
  • Glucosamine
  • Acetylglucosamine
Topics
  • Acetylgalactosamine (analogs & derivatives, therapeutic use)
  • Acetylglucosamine (analogs & derivatives, therapeutic use)
  • Animals
  • Antineoplastic Agents
  • Carcinoma, Ehrlich Tumor (drug therapy, immunology)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Female
  • Galactosamine (analogs & derivatives)
  • Glucosamine (analogs & derivatives)
  • Immunity (drug effects)
  • Leukemia L1210 (drug therapy)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: